Quotient Limited Announces Pricing of Underwritten Offering of Ordinary Shares
July 29, 2016 09:15 ET
|
Quotient Limited
JERSEY, Channel Islands, July 29, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the pricing of an underwritten public offering...
Quotient Limited Announces Proposed Underwritten Offering of Ordinary Shares
July 28, 2016 16:10 ET
|
Quotient Limited
JERSEY, Channel Islands, July 28, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that it intends to commence an underwritten...
Quotient Limited Provides Update on the MosaiQ™ Development Plan and Reports Preliminary Fiscal First Quarter 2017 Revenues
July 11, 2016 16:15 ET
|
Quotient Limited
Manufacturing system for MosaiQ™ consumables meeting design expectationsField trial instruments successfully pass rigorous internal evaluationMinor manufacturing facility modification recently...
Quotient Limited to Participate in Jefferies 2016 Global Healthcare Conference
May 31, 2016 08:30 ET
|
Quotient Limited
JERSEY, Channel Islands, May 31, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the company’s Chairman & CEO, Paul Cowan,...
Quotient Limited Reports Continued Progress on the Development of MosaiQ™ and Fourth Quarter and Fiscal Year 2016 Financial Results
May 23, 2016 16:17 ET
|
Quotient Limited
Completed commissioning of initial manufacturing system for MosaiQTM consumablesFirst field trial instruments received for internal evaluation and validationGenerated positive study results for...
Quotient Limited to Report Fourth Quarter Fiscal 2016 Financial Results and Host Conference Call
May 11, 2016 08:02 ET
|
Quotient Limited
JERSEY, Channel Islands, May 11, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fourth...
Quotient Limited to Participate in UBS Global Healthcare Conference
May 11, 2016 08:00 ET
|
Quotient Limited
JERSEY, Channel Islands, May 11, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the company’s Chairman & CEO, Paul Cowan,...
Quotient Limited Announces Positive MosaiQ™ Serological Disease Screening Results
April 13, 2016 16:06 ET
|
Quotient Limited
JERSEY, Channel Islands, April 13, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that results generated using the MosaiQTM...
Quotient Limited Announces Positive Serological Disease Screening Results and Provides MosaiQ™ Development Program Update
January 11, 2016 07:01 ET
|
Quotient Limited
JERSEY, Channel Islands, Jan. 11, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, will present the following update on the MosaiQ™ development...
Quotient Limited to Expand Capability of Its MosaiQ™ Next-Generation Transfusion Diagnostics Platform to Include Nucleic Acid Testing
January 11, 2016 07:00 ET
|
Quotient Limited
Initial feasibility study demonstrates ability to detect nucleic acid using MosaiQTMPotential for a single unified platform to perform blood grouping along with serological and molecular disease...